Want to see JP:9273 full AI Analyst Report?
Koa Shoji Holdings Co., Ltd. (9273) AI Stock Analysis
Top Page
Koa Shoji Holdings Co., Ltd.
(TSE/TYO:9273)
The score is driven primarily by strong financial performance (improving margins, low leverage) and supportive valuation (low P/E with a meaningful dividend yield). These positives are tempered by a more mixed technical picture, with only modest momentum and the price still below longer-term moving averages.
Koa Shoji Holdings Co., Ltd. (9273) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 35.34B
- Dividend Yield
- 2.15%
- Average Volume (3M)
- 66.77K
- Price to Earnings (P/E)
- 9.4
- Beta (1Y)
- 0.77
- Revenue Growth
- 6.06%
- EPS Growth
- 3.04%
- Country
- Japan
- Employees
- 318
- Sector
- General
- Sector Strength
- 55
- Industry
- Drug Manufacturers - Specialty & Generic
Koa Shoji Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Koa Shoji Holdings Co.,Ltd., established in 1991 and headquartered in Yokohama, Japan, operates through its subsidiaries, engaging in a diverse array of pharmaceutical activities. The company sources and distributes active pharmaceutical ingredients...
How the Company Makes Money
null
Koa Shoji Holdings Co., Ltd. Financial Statement Overview
Summary
Strong overall fundamentals supported by improving profitability (net margin rising to ~15% by 2026) and a conservatively financed balance sheet (debt-to-equity improving to ~0.11). The main offset is uneven cash-flow conversion in 2022–2025 despite improvement in 2026, plus some inconsistency in year-to-year revenue growth.
Income Statement
82Very PositiveBalance Sheet
87Very PositiveCash Flow
74Positive| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.68B | 24.68B | 23.27B | 22.13B | 22.05B | 20.35B |
| Gross Profit | 8.00B | 8.00B | 7.70B | 6.64B | 6.44B | 5.93B |
| EBITDA | 6.04B | 6.09B | 6.08B | 5.11B | 4.79B | 4.44B |
| Net Income | 3.75B | 3.75B | 3.64B | 2.95B | 2.69B | 2.36B |
Balance Sheet | ||||||
| Total Assets | 39.53B | 39.53B | 36.11B | 32.00B | 28.46B | 26.25B |
| Cash, Cash Equivalents and Short-Term Investments | 17.58B | 17.58B | 14.92B | 13.95B | 10.77B | 9.12B |
| Total Debt | 3.32B | 3.32B | 2.46B | 2.84B | 3.18B | 3.56B |
| Total Liabilities | 8.35B | 8.35B | 7.99B | 6.95B | 7.54B | 7.58B |
| Stockholders Equity | 31.18B | 31.18B | 28.12B | 25.05B | 20.92B | 18.67B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 3.92B | 1.89B | 2.39B | 2.47B | 1.65B |
| Operating Cash Flow | 0 | 7.59B | 3.78B | 3.83B | 2.74B | 2.09B |
| Investing Cash Flow | 0 | -8.15B | -1.28B | -1.47B | -304.11M | -477.33M |
| Financing Cash Flow | 0 | 189.08M | -938.67M | 795.25M | -812.06M | -804.93M |
Koa Shoji Holdings Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9273, the sentiment is Positive. The current price of 839.00 is above the 20-day moving average (MA) of 814.20, above the 50-day MA of 781.52, and above the 200-day MA of 796.76, indicating a bullish trend. The MACD of 15.70 indicates Positive momentum. The RSI at 65.15 is Neutral, neither overbought nor oversold. The STOCH value of 48.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9273.
Koa Shoji Holdings Co., Ltd. Peers Comparison
Overall Rating
- JP:927376Outperform
JP:812971Outperform
JP:453468Neutral
JP:454065Neutral
JP:488752Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:9273 | 76Outperform | JPY 35.34B | 9.43 | ― | 2.15% | 6.06% | 3.04% |
| JP:8129 | 71Outperform | JPY 261.44B | 15.85 | ― | 5.24% | 3.55% | -25.21% |
| JP:4534 | 68Neutral | JPY 111.78B | 12.67 | 6.64% | 2.51% | 14.72% | 52.55% |
| JP:4540 | 65Neutral | JPY 292.34B | 9.43 | 9.68% | 4.14% | 10.38% | 19.96% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| JP:4887 | 52Neutral | JPY 166.10B | 22.10 | ― | 3.36% | 11.08% | 701.86% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:9273 | Koa Shoji Holdings Co., Ltd. | 839.00 | 75.57 | 9.90% | |
| JP:4540 | Tsumura & Co | 3821.00 | 390.65 | 11.39% | |
| JP:4534 | Mochida Pharmaceutical Co., Ltd. | 3285.00 | 406.97 | 14.14% | |
| JP:4887 | SAWAI GROUP HOLDINGS Co., Ltd. | 1666.50 | -120.38 | -6.74% | |
| JP:8129 | Toho Holdings Co., Ltd. | 4004.00 | -712.33 | -15.10% |
Koa Shoji Holdings Co., Ltd. Corporate Events
KOA Shoji Holdings Updates Capital-Efficient Management Focus
KOA Shoji Holdings Co., Ltd., a TSE Prime-listed company supporting pharmaceuticals from upstream, is refining its management approach with a sharper focus on capital efficiency and market valuation. The company’s activities indicate a role in...
Koa Shoji Holdings Outlines Financial Results and Medium- to Long-Term Strategy
Koa Shoji Holdings Co., Ltd., active in the upstream pharmaceuticals domain, emphasizes supporting drug-related businesses through products and services that underpin pharmaceutical development and supply. The company targets a role as a key partner...
Koa Shoji Holdings Posts Higher Sales and Profits, Plans Dividend Hike Despite Forecast Profit Dip
Koa Shoji Holdings reported consolidated net sales of ¥24.68 billion for the fiscal year ended June 30, 2026, up 6.1% year on year, with operating profit rising 2.3% to ¥5.48 billion and profit attributable to owners of parent increasing 3....
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026